Covered recipient · General Payments record
KELLY E TRAWICK
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$374.20
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.13 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $35.39 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.75 | 1 |
| ABBVIE INC. | $20.75 | 1 |
| Astellas Pharma US Inc | $20.22 | 1 |
| Novo Nordisk AS | $19.62 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.26 | 1 |
| Phadia US Inc. | $14.50 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.75 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108325868 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.64 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146993325 | CMS |
| Astellas Pharma US Inc | $20.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139497310 | CMS |
| Boston Scientific Corporation | $19.26 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092357994 | CMS |
| Lilly USA, LLC | $20.79 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135792190 | CMS |
| Lilly USA, LLC | $14.60 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135760102 | CMS |
| Novo Nordisk Inc | $19.62 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304537 | CMS |
| Phadia US Inc. | $14.50 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067581540 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153485613 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.